BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23164938)

  • 1. Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Lu P; Cloer C; Tucker JD; Lu Q
    Mol Ther; 2013 Jan; 21(1):210-6. PubMed ID: 23164938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Lu P; Tucker JD; Milazi S; Shah SN; Lu QL
    Gene Ther; 2014 Jan; 21(1):52-9. PubMed ID: 24131982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice.
    Wang M; Wu B; Tucker JD; Shah SN; Lu P; Bollinger LE; Lu Q
    Mol Ther Nucleic Acids; 2017 Dec; 9():120-131. PubMed ID: 29246291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
    Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
    J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Tucker JD; Lu P; Cloer C; Lu QL
    Hum Gene Ther; 2014 May; 25(5):419-27. PubMed ID: 24405395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
    Wang M; Wu B; Tucker JD; Lu P; Lu Q
    Int J Nanomedicine; 2015; 10():5635-46. PubMed ID: 26366082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
    Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
    Wang M; Wu B; Shah SN; Lu P; Lu Q
    Drug Deliv; 2017 Nov; 24(1):952-961. PubMed ID: 28633548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo.
    Hu Y; Wu B; Zillmer A; Lu P; Benrashid E; Wang M; Doran T; Shaban M; Wu X; Lu QL
    Mol Ther; 2010 Apr; 18(4):812-8. PubMed ID: 20087314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice.
    Wang M; Wu B; Tucker JD; Bollinger LE; Lu P; Lu Q
    Mol Ther Nucleic Acids; 2016 Aug; 5(8):e341. PubMed ID: 27483024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice.
    Wang M; Wu B; Shah SN; Lu P; Lu Q
    Mol Ther Nucleic Acids; 2018 Jun; 11():192-202. PubMed ID: 29858054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOTS-c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice.
    Ran N; Lin C; Leng L; Han G; Geng M; Wu Y; Bittner S; Moulton HM; Yin H
    EMBO Mol Med; 2021 Feb; 13(2):e12993. PubMed ID: 33337582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.
    Vila MC; Novak JS; Benny Klimek M; Li N; Morales M; Fritz AG; Edwards K; Boehler JF; Hogarth MW; Kinder TB; Zhang A; Mazala D; Fiorillo AA; Douglas B; Chen YW; van den Anker J; Lu QL; Hathout Y; Hoffman EP; Partridge TA; Nagaraju K
    J Pathol; 2019 Jul; 248(3):339-351. PubMed ID: 30883742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A; Thorogood FC; Dickson G; Graham IR
    Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ester amine) constructed from polyethylenimine and pluronic for gene delivery in vitro and in vivo.
    Wang M; Wu B; Tucker JD; Lu P; Lu Q
    Drug Deliv; 2016 Nov; 23(9):3224-3233. PubMed ID: 26960992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
    Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development.
    Wu B; Benrashid E; Lu P; Cloer C; Zillmer A; Shaban M; Lu QL
    PLoS One; 2011; 6(5):e19906. PubMed ID: 21611204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and mechanistic toxicology evaluation of exon skipping phosphorodiamidate morpholino oligomers in mdx mice.
    Sazani P; Ness KP; Weller DL; Poage D; Nelson K; Shrewsbury AS
    Int J Toxicol; 2011 May; 30(3):322-33. PubMed ID: 21540335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
    Yokota T; Nakamura A; Nagata T; Saito T; Kobayashi M; Aoki Y; Echigoya Y; Partridge T; Hoffman EP; Takeda S
    Nucleic Acid Ther; 2012 Oct; 22(5):306-15. PubMed ID: 22888777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.